KRW 13460.0
(1.58%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 579.72 Billion KRW | 14.78% |
2022 | 505.08 Billion KRW | -0.38% |
2021 | 506.99 Billion KRW | 3.65% |
2020 | 489.14 Billion KRW | 7.79% |
2019 | 453.77 Billion KRW | 5.16% |
2018 | 431.5 Billion KRW | -13.09% |
2017 | 496.47 Billion KRW | 1.78% |
2016 | 487.81 Billion KRW | -6.84% |
2015 | 523.63 Billion KRW | 22.3% |
2014 | 428.14 Billion KRW | 53.34% |
2013 | 279.21 Billion KRW | 25.41% |
2012 | 222.64 Billion KRW | 6.24% |
2011 | 209.57 Billion KRW | 3.73% |
2010 | 202.03 Billion KRW | -10.16% |
2009 | 224.89 Billion KRW | 75.56% |
2008 | 128.09 Billion KRW | 37.24% |
2007 | 93.34 Billion KRW | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 693.41 Billion KRW | 4.52% |
2024 Q1 | 663.42 Billion KRW | 14.44% |
2023 Q2 | 571.32 Billion KRW | 4.03% |
2023 FY | 579.72 Billion KRW | 14.78% |
2023 Q3 | 583.49 Billion KRW | 2.13% |
2023 Q4 | 579.72 Billion KRW | -0.65% |
2023 Q1 | 549.17 Billion KRW | 8.73% |
2022 Q4 | 505.08 Billion KRW | 0.13% |
2022 Q2 | 494.41 Billion KRW | -0.78% |
2022 FY | 505.08 Billion KRW | -0.38% |
2022 Q1 | 498.29 Billion KRW | -1.72% |
2022 Q3 | 504.4 Billion KRW | 2.02% |
2021 Q3 | 515.33 Billion KRW | -2.72% |
2021 Q2 | 529.73 Billion KRW | -2.57% |
2021 Q4 | 506.99 Billion KRW | -1.62% |
2021 FY | 506.99 Billion KRW | 3.65% |
2021 Q1 | 543.68 Billion KRW | 11.15% |
2020 FY | 489.14 Billion KRW | 7.79% |
2020 Q4 | 489.14 Billion KRW | -4.33% |
2020 Q2 | 520.97 Billion KRW | 7.08% |
2020 Q1 | 486.55 Billion KRW | 7.22% |
2020 Q3 | 511.29 Billion KRW | -1.86% |
2019 Q4 | 453.77 Billion KRW | 0.35% |
2019 FY | 453.77 Billion KRW | 5.16% |
2019 Q1 | 453.71 Billion KRW | 5.15% |
2019 Q2 | 442.55 Billion KRW | -2.46% |
2019 Q3 | 452.21 Billion KRW | 2.18% |
2018 Q2 | 496.67 Billion KRW | -2.68% |
2018 Q1 | 510.33 Billion KRW | 2.79% |
2018 FY | 431.5 Billion KRW | -13.09% |
2018 Q4 | 431.5 Billion KRW | -7.59% |
2018 Q3 | 466.93 Billion KRW | -5.99% |
2017 Q4 | 496.47 Billion KRW | 0.4% |
2017 Q2 | 492.51 Billion KRW | 0.4% |
2017 Q1 | 490.56 Billion KRW | 0.56% |
2017 FY | 496.47 Billion KRW | 1.78% |
2017 Q3 | 494.51 Billion KRW | 0.4% |
2016 Q4 | 487.81 Billion KRW | -5.95% |
2016 Q3 | 518.68 Billion KRW | -2.29% |
2016 Q2 | 530.84 Billion KRW | -0.36% |
2016 Q1 | 532.74 Billion KRW | 1.74% |
2016 FY | 487.81 Billion KRW | -6.84% |
2015 FY | 523.63 Billion KRW | 22.3% |
2015 Q1 | 431.89 Billion KRW | 0.87% |
2015 Q2 | 441.17 Billion KRW | 2.15% |
2015 Q3 | 505.02 Billion KRW | 14.47% |
2015 Q4 | 523.63 Billion KRW | 3.68% |
2014 Q4 | 428.14 Billion KRW | 45.38% |
2014 Q3 | 294.51 Billion KRW | 3.03% |
2014 Q2 | 285.84 Billion KRW | 4.16% |
2014 Q1 | 274.42 Billion KRW | -1.72% |
2014 FY | 428.14 Billion KRW | 53.34% |
2013 FY | 279.21 Billion KRW | 25.41% |
2013 Q1 | 240.47 Billion KRW | 8.01% |
2013 Q2 | 263.77 Billion KRW | 9.69% |
2013 Q3 | 256.56 Billion KRW | -2.73% |
2013 Q4 | 279.21 Billion KRW | 8.83% |
2012 FY | 222.64 Billion KRW | 6.24% |
2012 Q3 | 231.04 Billion KRW | -1.34% |
2012 Q4 | 222.64 Billion KRW | -3.63% |
2012 Q1 | 225.07 Billion KRW | 7.4% |
2012 Q2 | 234.17 Billion KRW | 4.04% |
2011 FY | 209.57 Billion KRW | 3.73% |
2011 Q4 | 209.57 Billion KRW | 4.77% |
2011 Q3 | 200.02 Billion KRW | -4.07% |
2011 Q2 | 208.51 Billion KRW | 1.15% |
2011 Q1 | 206.13 Billion KRW | 0.0% |
2010 Q3 | - KRW | 0.0% |
2010 FY | 202.03 Billion KRW | -10.16% |
2010 Q1 | - KRW | 0.0% |
2010 Q2 | - KRW | 0.0% |
2009 FY | 224.89 Billion KRW | 75.56% |
2009 Q3 | - KRW | 0.0% |
2009 Q2 | - KRW | 0.0% |
2009 Q1 | - KRW | 0.0% |
2008 Q2 | - KRW | 0.0% |
2008 Q3 | - KRW | 0.0% |
2008 FY | 128.09 Billion KRW | 37.24% |
2008 Q1 | - KRW | 0.0% |
2007 FY | 93.34 Billion KRW | 0.0% |
2007 Q1 | - KRW | 0.0% |
2007 Q2 | - KRW | 0.0% |
2007 Q3 | - KRW | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
ORIENT BIO Inc. | 3.65 Billion KRW | -15763.805% |
Green Cross Holdings Corporation | 516.24 Billion KRW | -12.297% |
Pharmicell Co., Ltd. | 20.87 Billion KRW | -2677.491% |
Green Cross Corporation | 516.24 Billion KRW | -12.297% |
GeneOne Life Science, Inc. | 14.89 Billion KRW | -3791.593% |
Celltrion, Inc. | 3041.45 Billion KRW | 80.939% |
Samsung Biologics Co.,Ltd. | 2641.36 Billion KRW | 78.052% |
SK bioscience Co.,Ltd. | 80.64 Billion KRW | -618.826% |
SK Biopharmaceuticals Co., Ltd. | 102.52 Billion KRW | -465.448% |
Prestige BioPharma Limited | 18.1 Billion KRW | -3102.389% |